Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM Stock Report

Market Cap: ₹924.8b

Torrent Pharmaceuticals Dividend

Dividend criteria checks 4/6

Torrent Pharmaceuticals is a dividend paying company with a current yield of 1.1% that is well covered by earnings.

Key information

1.1%

Dividend yield

68%

Payout ratio

Industry average yield0.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₹44.15
Dividend yield forecast in 3Y1.0%

Recent dividend updates

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Recent updates

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Apr 16
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 03
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Jan 07
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Nov 14
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jun 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Mar 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 25
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Jun 02
Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

May 25
Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Feb 18
A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Jan 27
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Jan 04
Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

Dec 14
Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Nov 07
A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Sep 30
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Sep 01
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 02
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Jun 01
I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

May 14
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 23
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More

Mar 02
The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More

Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?

Feb 10
Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?

Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?

Jan 19
Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?

Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?

Dec 29
Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?

Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?

Dec 08
Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?

Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%

Nov 16
Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%

The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 28
The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Here's Why We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Well Worth Watching

Oct 07
Here's Why We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Well Worth Watching

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Delivered A Better ROE Than Its Industry

Sep 16
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Delivered A Better ROE Than Its Industry

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: TORNTPHARM's dividend payments have been volatile in the past 10 years.

Growing Dividend: TORNTPHARM's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Torrent Pharmaceuticals Dividend Yield vs Market
How does TORNTPHARM dividend yield compare to the market?
SegmentDividend Yield
Company (TORNTPHARM)1.1%
Market Bottom 25% (IN)0.3%
Market Top 25% (IN)1.2%
Industry Average (Pharmaceuticals)0.7%
Analyst forecast in 3 Years (TORNTPHARM)1.0%

Notable Dividend: TORNTPHARM's dividend (1.1%) is higher than the bottom 25% of dividend payers in the Indian market (0.26%).

High Dividend: TORNTPHARM's dividend (1.1%) is low compared to the top 25% of dividend payers in the Indian market (1.18%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (67.9%), TORNTPHARM's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (41.9%), TORNTPHARM's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.